SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-15-002362
Filing Date
2015-09-08
Accepted
2015-09-08 14:55:06
Documents
2
Period of Report
2015-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K entiabiosciences8k090815.htm 8-K 26374
2 EX-10.1 ex10-1.htm EX-10.1 97484
  Complete submission text file 0001185185-15-002362.txt   125517
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 844-559-9910
Entia Biosciences, Inc. (Filer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52864 | Film No.: 151096442
SIC: 2833 Medicinal Chemicals & Botanical Products